Metrikler
Yayın
11
Araştırma Alanları
Tıp
Dahili Tıp Bilimleri
Sağlık Bilimleri
Makaleler
Tümü (11)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (11)
Scopus (11)
TRDizin (2)
2025
20251. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience
Ediboglu E. D., KALYONCU U., SOLMAZ D., YAŞAR BİLGE N. Ş., Yilmaz S., Bes C., et al.
ARCHIVES OF RHEUMATOLOGY
, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)
2024
20242. Computed tomography imaging-based radiologic evaluation of pulmonary artery thrombosis in a series of patients with Behcet's disease
GERME Ş. A., ÖZSOY Z., Bulat B., DURHAN G., FIRLATAN B., KILIÇ L., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.27, sa.7, 2024 (SCI-Expanded, Scopus)
2024
20243. Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication
ÖZSOY Z., AYAN G., DURHAN G., KALYONCU U.
Rheumatology (United Kingdom)
, cilt.63, sa.4, ss.1147-1152, 2024 (SCI-Expanded, Scopus)
2024
20244. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)
BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine
, 2024 (SCI-Expanded, Scopus)
2024
20245. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates
Sandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.
International Journal of Rheumatic Diseases
, cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)
2023
20236. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.
Rheumatology and Therapy
, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
2023
20237. Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
ÖZSOY Z., ÖZDEMİR A., EKİCİ M., BİLGİN E., KILIÇ L., KİRAZ S., et al.
Rheumatology International
, cilt.43, sa.8, ss.1445-1451, 2023 (SCI-Expanded, Scopus)
2023
20238. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone
Kiracı M., BİLGİN E., Duran E., Farisoğulları B., Bölek E., Yardımcı G., et al.
Scandinavian Journal of Rheumatology
, cilt.52, sa.5, ss.530-538, 2023 (SCI-Expanded, Scopus)
2022
20229. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results
AYAN G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., DURAN E., et al.
CLINICAL RHEUMATOLOGY
, cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus)
2022
202210. Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
Bostan E., GÜLSEREN D., ÖZSOY Z., Ergen F. B.
Archives of Rheumatology
, cilt.37, sa.1, ss.148-149, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202111. Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever
Kiraci M., BİLGİN E., Duran E., Farisogullari B., Bolek E. C., YARDIMCI G. K., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.73, ss.771-773, 2021 (SCI-Expanded, Scopus)